NEA Management Company, LLC

NEA Management Company, LLC reported 25 holdings worth US$1.36B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

NEA Management Company, LLC reported 25 holdings worth US$1.36B as of Sep 30, 2026. Largest: MBX Biosciences, Inc., SpyGlass Pharma, Inc. and Trevi Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
25
Value as reported
US$1.36B

The filing in full

CompanySharesValue as reported% of portfolio
MBX Biosciences, Inc.3.61MUS$212M15.5%
SpyGlass Pharma, Inc.7.39MUS$192M14.1%
Trevi Therapeutics, Inc.13.2MUS$189M13.9%
Celcuity Inc.1.71MUS$136M10.0%
Savara, Inc.24.5MUS$126M9.3%
Zenas BioPharma, Inc.4.02MUS$109M8.0%
Monte Rosa Therapeutics, Inc.6.69MUS$79.8M5.9%
Aurinia Pharmaceuticals Inc3.97MUS$64.3M4.7%
Coursera, Inc.12.9MUS$63.8M4.7%
ORIC Pharmaceuticals, Inc.4.12MUS$55.5M4.1%
Phathom Pharmaceuticals, Inc.1.96MUS$14.3M1.0%
Korro Bio, Inc.1.3MUS$12.9M0.94%
Nkarta, Inc.3.57MUS$9.35M0.69%
Champions Oncology, Inc.1.71MUS$8.57M0.63%
Black Diamond Therapeutics, Inc.4.45MUS$8.39M0.61%
Inventiva SA1.46MUS$5.4M0.40%
CVRx, Inc.1.95MUS$3.42M0.25%
Marker Therapeutics, Inc.1.63MUS$1.74M0.13%
LeonaBio, Inc.464KUS$1.66M0.12%
OnKure Therapeutics, Inc.479KUS$1.3M0.10%
ImageneBio, Inc.50,005US$229K0.02%
Gossamer Bio, Inc.12,500US$148K0.01%
Karyopharm Therapeutics Inc.0US$00.00%

Source

Download original · View original at SEC

Related